Company profile

Basilea Pharmaceutica AG, Allschwil insider transactions

BSLN

Management transactions

Shareholding disclosures

364

First disclosure

24.03.2004

Last disclosure

16.09.2026

Company summary

Over 90 days: 0 purchases (CHF 0.00) and 16 sales (CHF 1.4 M). Disclosed flows are net selling.

Latest purchase: —
Net flow 90 d: CHF -1’406’799
Top shareholder: 14.961%

Latest priced trade (01.10.2026): CHF 61 k, 1.6× the median of 26 earlier same-direction trades over one year. Compare with its own history, not another company’s.

This page brings together all Basilea Pharmaceutica AG, Allschwil (BSLN) insider transactions: 35 management transactions and 364 significant shareholding disclosures published by SIX Exchange Regulation, from 24.03.2004 to 16.09.2026.

Detailed context

SIX Exchange Regulation has published 35 management transactions and 364 significant shareholding disclosures regarding Basilea Pharmaceutica AG, Allschwil, including various insider transactions. Over the last 90 days, there were 0 purchases for CHF 0 and 16 sales totaling CHF 1'406'799, with the latest management transaction dated 2026-10-01. The largest declared shareholders by voting rights include Basilea Pharmaceutica Ltd at 33.25%, Basilea Pharmaceutica AG at 25.14%, Basilea Pharmaceutica AG, Allschwil at 24.99%, and Basilea Pharmaceutica Ltd, Allschwil at 14.961%.

Insider barometer

90 days

16 transactions

CHF -1’406’799

Net selling

Declared purchases 0%Declared sales 100%

Net flowNet selling

Declared purchases

CHF 0.00

Declared sales

CHF 1’406’799

Latest transaction

01.10.2026

Largest purchase

—

Largest sale

CHF 329’229

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow Basilea Pharmaceutica AG, Allschwil’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open